2020 MIPS Reporting Information & New Version Update

EyeMD EMR 2.0 Version Update
We are currently well into Stage 2 of our roll out and have migrated approximately 30% of our clients to the new version. Our largest client with 84 physicians and 625 employees migrated last month, and they are doing great and loving the new version. We are quickly reaching the point where we can perform a mass migration of all remaining clients and expect all remaining clients to have the opportunity to upgrade by the end of this year. If you are in Stage 2 and have not yet been given the opportunity to upgrade, we will be contacting you soon. If you signed up for Stage 3 (or never signed up) and would like to be moved to Stage 2, please contact Customer Service.

COVID-19 Impact on Practices
Many customers have been severely impacted by COVID and as a result, did not wish to proceed with the migration to 2.0 when given the opportunity to migrate. Although a few customers took advantage of the reduced patient volumes and migrated, most held off due to challenges brought by staff working remotely, being laid off, furloughed, etc. Many practices decided to hold off on migration until they were in a better, more certain position.

MIPS Extreme & Uncontrollable Circumstances and PI Interoperability Hardship Exception
The MIPS Extreme & Uncontrollable Circumstances and PI Interoperability Hardship Exception allows your practice to request reweighting for all MIPS performance categories if you have been significantly impacted by COVID 19. This exception recognizes the challenges most practices faced and gives your practice more time to migrate while avoiding penalties.

Even if you plan to report for 2020, AAO is recommending that all eligible practices apply for both a MIPS Extreme & Uncontrollable Circumstances Application and a PI Interoperability Hardship Exception Application as most practices have likely been significantly impacted by COVID-19. We agree with the Academy and urge all eligible customers to apply for both exceptions.

  • The 2020 extreme and uncontrollable circumstance application is open through December 31, 2020, allowing clinicians, groups, and virtual groups to request reweighting of one or more MIPS performance categories to 0%.
  • When approved, the performance categories included in the application are weighted at 0% and will not contribute to your final score unless you submit MIPS data for the 2020 performance period.
  • Data submissions for a given category will void approved category exceptions. As a result, if you apply and intend to rely on that exception, DO NOT submit any data for that category.

We urge all eligible customers still on EyeMD EMR version 1.0 to apply for these exceptions.

If you need assistance with filing these applications, please contact Customer Service. For more information regarding the Hardship Exception click here.

2015 Certification Status
EyeMD EMR 2.0 is a 2015 Edition certified product. That said, there are a few outstanding certification items that are required for us to complete before you can attest for PI in 2020. Certification testing is currently scheduled for December 14-16, before the deadline of December 31st. Rest assured that clients that upgraded to version 2.0 will be able to attest for PI for the 2020 reporting year if they prefer that option over the hardship exception.

In addition, there is an emergency executive order being considered to further extend compliance dates and timeframes as a result of COVID. We will keep you posted as information becomes available.

Share this Post:

Related Posts

MIPS Highlights 2024 – Q4

As the Year Comes to a Close The team at EyeMD EMR Healthcare Systems would like to extend our heartfelt gratitude for your trust and partnership over the past year. We deeply appreciate your continued support and wish you great success and a joyful start to the New Year. Important MIPS Deadlines As we approach year-end, please keep the following key dates in mind for the MIPS attestation process: December 31, 2024: End of the 2024 MIPS attestation period December 31, 2024: Deadline for the MIPS Extreme & Uncontrollable Circumstances (EUC) Exception and the Promoting Interoperability Hardship application (closes at 8:00 PM ET) January 1,

Read More »

MIPS Highlights 2024 – Q3

With the kids back in school, it’s time to catch up on your MIPS homework! That means it’s time for the Security Risk Assessment (SRA)! What is SRA? The Security Risk Analysis (SRA) is a critical process for both MIPS and HIPAA. Under MIPS, it directly impacts a provider’s performance score in the Promoting Interoperability (PI) category, while under HIPAA, it is a legal requirement to ensure the protection of electronic Protected Health Information (ePHI). MIPS (Merit-based Incentive Payment System): As part of the Promoting Interoperability (PI) category, healthcare providers are required to conduct or review a Security Risk Analysis (SRA) to protect electronic health

Read More »
FTC logo

Federal Trade Commission Eyeglass Rule – Effective September 2024

The Federal Trade Commission (FTC) Eyeglass Rule, officially titled 16 CFR Part 456, is a regulation that mandates eyecare providers to provide patients with a copy of their eyeglass prescription immediately after an eye examination. This rule applies regardless of whether the patient requests the prescription, and even if the examination does not indicate a change in the prescription.   The FTC Eyeglass Rule will go into effect September 2024.   Rule Highlights: Automatic Release of Prescription: After completing an eye exam, you must provide the patient with a copy of their eyeglass prescription, even if they do not ask for it. No Conditions or

Read More »

Worldwide Cloud Outage Impact – Restored

Our support operations have been fully restored. Services for our credit card processing partner Nexio have also been fully restored. Eligibility checks for most carriers have been restored as well. A banner in the PM will provide status updates for the remaining carriers. We thank you for your patience and apologize for the inconvenience.

Read More »

Worldwide Cloud Outage Impact

 A software update from the cybersecurity company CrowdStrike has inadvertently disrupted IT systems globally. Although most of our systems were unaffected, our primary remote support tool (LogMeIn Rescue) is currently offline. Consequently, our remote support capabilities have been impacted. Our support team is unable to access customer systems using this tool. However, we can connect to remote systems using an alternative, customer-initiated tool. As a result, we are unable to perform certain remote tasks, which may lead to support delays and cancellations. Additionally, our credit card processing partner, Nexio, is currently unable to process credit card transactions, and certain eligibility checks are failing. We thank

Read More »

Welcome to NewCrop Rx v2- Exciting Updates and Enhanced Features!

We are excited to introduce NewCrop Rx v2!   Our development team has been collaborating closely with our ePrescribing vendor to bring you the latest version of NewCrop Rx. The new platform is designed to enhance usability and reliability, offering a host of new features including: A fresh, modern, and intuitive interface. Real-time benefits information (including alternative drug options). Customized SIG builders. New drop-down menus and much more! To ensure a seamless transition, please review the Migration Guide prior to your transition.   To assist you in mastering the ePrescribing process and optimizing your transition experience, the following resources are also available: Get Started Guide

Read More »

Worldwide Cloud Outage Impact

 A software update from the cybersecurity company CrowdStrike has inadvertently disrupted IT systems globally. Although most of our systems were unaffected, our primary remote support

Learn More »
EyeMD EMR Named 2024 Best In KLAS: Ambulatory **Ophthalmology** EMR

EyeMD EMR Named 2024 Best In KLAS: Ambulatory **Ophthalmology** EMR
More Information More Information
More Information More Information